Drug profile · INN
trimethoprim hydrochloride
PRIMSOL
trimethoprim hydrochloride (PRIMSOL) is a bacterial dihydrofolate reductase inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — trimethoprim hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
trimethoprim hydrochloride (PRIMSOL) is a bacterial dihydrofolate reductase inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Bacterial dihydrofolate reductase inhibitor
Primary target: Dihydrofolate reductase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is trimethoprim hydrochloride?
trimethoprim hydrochloride (PRIMSOL) is a bacterial dihydrofolate reductase inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for trimethoprim hydrochloride?
PRIMSOL is a marketed brand name for trimethoprim hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of trimethoprim hydrochloride?
trimethoprim hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.